6.
Chio A, Mora G, Moglia C, Manera U, Canosa A, Cammarosano S
. Secular Trends of Amyotrophic Lateral Sclerosis: The Piemonte and Valle d'Aosta Register. JAMA Neurol. 2017; 74(9):1097-1104.
PMC: 5710181.
DOI: 10.1001/jamaneurol.2017.1387.
View
7.
Tobin K, Gilthorpe M, Rooney J, Heverin M, Vajda A, Staines A
. Age-period-cohort analysis of trends in amyotrophic lateral sclerosis incidence. J Neurol. 2016; 263(10):1919-26.
DOI: 10.1007/s00415-016-8215-z.
View
8.
Fang F, Valdimarsdottir U, Bellocco R, Ronnevi L, Sparen P, Fall K
. Amyotrophic lateral sclerosis in Sweden, 1991-2005. Arch Neurol. 2009; 66(4):515-9.
DOI: 10.1001/archneurol.2009.13.
View
9.
Fontana A, Marin B, Luna J, Beghi E, Logroscino G, Boumediene F
. Time-trend evolution and determinants of sex ratio in Amyotrophic Lateral Sclerosis: a dose-response meta-analysis. J Neurol. 2021; 268(8):2973-2984.
DOI: 10.1007/s00415-021-10464-2.
View
10.
Uenal H, Rosenbohm A, Kufeldt J, Weydt P, Goder K, Ludolph A
. Incidence and geographical variation of amyotrophic lateral sclerosis (ALS) in Southern Germany--completeness of the ALS registry Swabia. PLoS One. 2014; 9(4):e93932.
PMC: 3983245.
DOI: 10.1371/journal.pone.0093932.
View
11.
Pupillo E, Bianchi E, Vitelli E, Beghi E
. ALS incidence and population aging in Northern Italy. Amyotroph Lateral Scler Frontotemporal Degener. 2021; 23(3-4):236-241.
DOI: 10.1080/21678421.2021.1953076.
View
12.
Benjaminsen E, Alstadhaug K, Gulsvik M, Baloch F, Odeh F
. Amyotrophic lateral sclerosis in Nordland county, Norway, 2000-2015: prevalence, incidence, and clinical features. Amyotroph Lateral Scler Frontotemporal Degener. 2018; 19(7-8):522-527.
DOI: 10.1080/21678421.2018.1513534.
View
13.
Brown C, Lally C, Kupelian V, Flanders W
. Estimated Prevalence and Incidence of Amyotrophic Lateral Sclerosis and SOD1 and C9orf72 Genetic Variants. Neuroepidemiology. 2021; 55(5):342-353.
DOI: 10.1159/000516752.
View
14.
Doi Y, Yokoyama T, Tango T, Takahashi K, Fujimoto K, Nakano I
. Temporal trends and geographic clusters of mortality from amyotrophic lateral sclerosis in Japan, 1995-2004. J Neurol Sci. 2010; 298(1-2):78-84.
DOI: 10.1016/j.jns.2010.08.004.
View
15.
Longinetti E, Fang F
. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019; 32(5):771-776.
PMC: 6735526.
DOI: 10.1097/WCO.0000000000000730.
View
16.
Brooks B, Miller R, Swash M, Munsat T
. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001; 1(5):293-9.
DOI: 10.1080/146608200300079536.
View
17.
Chio A, Logroscino G, Traynor B, Collins J, Simeone J, Goldstein L
. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013; 41(2):118-30.
PMC: 4049265.
DOI: 10.1159/000351153.
View
18.
Henning F, Heckmann J, Naidu K, Vlok L, Cross H, Marin B
. Incidence of motor neuron disease/amyotrophic lateral sclerosis in South Africa: a 4-year prospective study. Eur J Neurol. 2020; 28(1):81-89.
DOI: 10.1111/ene.14499.
View
19.
Gao M, Liu N, Li X, Chao L, Lin H, Wang Y
. Epidemiology and factors predicting survival of amyotrophic lateral sclerosis in a large Chinese cohort. Chin Med J (Engl). 2021; 134(18):2231-2236.
PMC: 8478368.
DOI: 10.1097/CM9.0000000000001679.
View
20.
Leighton D, Newton J, Stephenson L, Colville S, Davenport R, Gorrie G
. Changing epidemiology of motor neurone disease in Scotland. J Neurol. 2019; 266(4):817-825.
DOI: 10.1007/s00415-019-09190-7.
View